FIELD: pharmaceutical chemistry.
SUBSTANCE: group of inventions relates to pharmaceutical chemistry and includes specific compounds specified in the claims, a pharmaceutical composition based on them, a method for the treatment of a disease or a disorder mediated by transglutaminase 2, and the use of compounds in the production of a drug.
EFFECT: compounds, which inhibit transglutaminase 2 (TG2).
22 cl, 1 tbl, 109 ex
| Title |
Year |
Author |
Number |
| SUBSTITUTED BENZENE COMPOUNDS |
2012 |
- Kuntts Kevin Uejn
- Chesuort Richard
- Dunkan Kennet Uillyam
- Kajlkhak Khajke
- Varkholik Natali
- Klaus Kristin
- Natson Sara K.
- Vigl Timoti Dzhejms Nelson
- Seki Masasi
|
RU2629118C2 |
| TETRASUBSTITUTED ALKENE COMPOUNDS AND USE THEREOF |
2016 |
- Bock, Mark
- Hao, Ming-Hong
- Korpal, Manav
- Nyavanandi, Vijay Kumar
- Puyang, Xiaoling
- Samajdar, Susanta
- Smith, Peter Gerard
- Wang, John
- Zheng, Guo Zhu
- Zhu, Ping
|
RU2733741C2 |
| PYRIDINONE DERIVATIVES AS TISSUE TRANSGLUTAMINASE INHIBITORS |
2013 |
- Byukhold Kristian
- Gerlakh Uve
- Khils Martin
- Pasternak Ralf
- Veber Jokhannes
|
RU2652987C2 |
| ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS |
2012 |
- Kuntts Kevin Uejn
- Chesuort Richard
- Dunkan Kennet Uillyam
- Kajlkhak Khajke
- Varkholik Natali
- Klaus Kristin
- Seki Masasi
- Sirotori Syudzi
- Kavano Satosi
- Vigl Timoti Dzhejms Nelson
|
RU2632193C2 |
| HALOALLYLAMINE SULFONE DERIVATIVE AS LYSILOXIDASE INHIBITORS AND THEIR USE |
2019 |
- Findlay Alison Dorothy
- Turner Craig Ivan
- Deodhar Mandar
- Foot Jonathan Stuart
- Jarolimek Wolfgang
- Zhou Wenbin
- Buson Alberto
- Greko Anzhelik Elza
|
RU2801092C2 |
| NEW SULPHONAMIDE CARBOXAMIDE COMPOUNDS |
2018 |
- Cooper Matthew
- Miller David
- Macleod Angus
- Van Wiltenburg Jimmy
- Thom Stephen
- St-Gallay Stephen
- Shannon Jonathan
|
RU2808572C2 |
| MENIN-MLL INTERACTION INHIBITORS |
2017 |
- Kakatyan Salvasion
- Klejrmon Devid A.
- Dillard Lourens Vejn
- Dun Chengo
- Fan I
- Tszya Lantsi
- Lotesta Stefen D.
- Markus Endryu
- Morales-Ramos Enzhel
- Singkh Suresh B.
- Venkatraman Shankar
- Yuan Tszin
- Chzhen Yatszyun
- Chzhuan Linkhan
- Perent Stefan D.
- Khyuston Trejvis L.
|
RU2799820C2 |
| COMPOSITIONS AND METHODS FOR JAK PATH INHIBITION |
2011 |
- Li Khuej
- Khekrodt Tilo Dzh.
- Chen Yan
- Makmartri Darren Dzhon
- Tejlor Vanessa
- Singkh Radzhinder
- Din Pinyuj
- Jen Rouz
|
RU2672100C2 |
| ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY |
2016 |
- Kessari Dzhanni
- Govard Stiven
- Bak Ildiko Mariya
- Kons Bendzhamin Devid
- Dzhonson Kristofer Norbert
- Kholvi Rian Sara
- Ris Devid Charlz
- St. Denis Dzheffri Devid
- Tamanini Emiliano
- Golding Bernard Tomas
- Khardkasl Ian Robert
- Kano Selin Florens
- Miller Dunkan Charlz
- Kalli Sara
- Noubl Martin Edvard Myantyulya
- Griffin Rodzher Dzhon
- Osborn Dzhejms Deniel
- Pich Dzhoan
- Lyuis Aruel
- Kherst Kim Luiza
- Uittaker Bendzhamin Pol
- Uotson Devid Uin
- Mitchell Dejl Robert
|
RU2794333C1 |
| 3-CARBAMOYL-2-PYRIDONE DERIVATIVES |
2005 |
- Isizuka Natsuki
- Sasatani Takasi
- Khiramatsu Josikharu
- Inagaki Masanao
- Odan Masakhide
- Khasizume Khirosi
- Mitsumori Susumu
- Fudzii Jasukhiko
- Fukui Josikazu
- Vatanabe Khideaki
- Sato Dzun
|
RU2392271C2 |
